Application of Next-Generation Sequencing to Identify Genes and Mutations Causing Autosomal Dominant Retinitis Pigmentosa (adRP)

被引:29
作者
Daiger, Stephen P. [1 ]
Bowne, Sara J. [1 ]
Sullivan, Lori S. [1 ]
Blanton, Susan H. [2 ]
Weinstock, George M. [3 ]
Koboldt, Daniel C. [3 ]
Fulton, Robert S. [3 ]
Larsen, David [3 ]
Humphries, Peter [4 ]
Humphries, Marian M. [4 ]
Pierce, Eric A. [5 ]
Chen, Rui [6 ]
Li, Yumei [6 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA
[2] Univ Miami, Miami Inst Human Genom, Miami, FL USA
[3] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA
[4] Univ Dublin Trinity Coll, Dept Genet, Dublin 2, Ireland
[5] Massachusetts Eye & Ear Infirm, Ocular Genom Inst, Boston, MA 02114 USA
[6] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
来源
RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY | 2014年 / 801卷
关键词
Retinitis pigmentosa; Next-generation sequencing; Linkage mapping; Mutation prevalence; Retinal gene capture; Whole-exome sequencing; FAMILIES; PREVALENCE; ACCOUNT;
D O I
10.1007/978-1-4614-3209-8_16
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The goal of our research is to identify genes and mutations causing autosomal dominant retinitis pigmentosa (adRP). For this purpose we established a cohort of more than 250 independently ascertained families with adRP in the Houston Laboratory for Molecular Diagnosis of Inherited Eye Diseases. Affected members of each family were screened for disease-causing mutations in genes and gene regions that are commonly associated with adRP. By this approach, we detected mutations in 65% of the families, leaving 85 families that are likely to harbor mutations outside of the "common" regions or in novel genes. Of these, 32 families were tested by several types of next-generation sequencing (NGS), including (a) targeted polymerase chain reaction (PCR) NGS, (b) whole exome NGS, and (c) targeted retinal-capture NGS. We detected mutations in 11 of these families (31%) bringing the total detected in the adRP cohort to 70%. Several large families have also been tested for linkage using Afymetrix single nucleotide polymorphism (SNP) arrays.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 14 条
[1]   The molecular basis of human retinal and vitreoretinal diseases [J].
Berger, Wolfgang ;
Kloeckener-Gruissem, Barbara ;
Neidhardt, John .
PROGRESS IN RETINAL AND EYE RESEARCH, 2010, 29 (05) :335-375
[2]  
Bowne SJ, 2011, EUR J HUM GENET, V19, P1074, DOI 10.1038/ejhg.2011.86
[3]  
Bowne SJ, 2010, INVEST OPHTH VIS SCI, V52, P494
[4]   Mutations in the X-Linked Retinitis Pigmentosa Genes RPGR and RP2 Found in 8.5% of Families with a Provisional Diagnosis of Autosomal Dominant Retinitis Pigmentosa [J].
Churchill, Jennifer D. ;
Bowne, Sara J. ;
Sullivan, Lori S. ;
Lewis, Richard Alan ;
Wheaton, Dianna K. ;
Birch, David G. ;
Branham, Kari E. ;
Heckenlively, John R. ;
Daiger, Stephen P. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (02) :1411-1416
[5]  
Daiger SP, 2008, ADV EXP MED BIOL, V613, P203, DOI 10.1007/978-0-387-74904-4_23
[6]   Perspective on genes and mutations causing retinitis pigmentosa [J].
Daiger, Stephen P. ;
Bowne, Sara J. ;
Sullivan, Lori S. .
ARCHIVES OF OPHTHALMOLOGY, 2007, 125 (02) :151-158
[7]   Targeted High-Throughput DNA Sequencing for Gene Discovery in Retinitis Pigmentosa [J].
Daiger, Stephen P. ;
Sullivan, Lori S. ;
Bowne, Sara J. ;
Birch, David G. ;
Heckenlively, John R. ;
Pierce, Eric A. ;
Weinstock, George M. .
RETINAL DEGENERATIVE DISEASES: LABORATORY AND THERAPEUTIC INVESTIGATIONS, 2010, 664 :325-331
[8]  
Daiger Stephen P., 2013, RET INF NETW
[9]   PLINK: A tool set for whole-genome association and population-based linkage analyses [J].
Purcell, Shaun ;
Neale, Benjamin ;
Todd-Brown, Kathe ;
Thomas, Lori ;
Ferreira, Manuel A. R. ;
Bender, David ;
Maller, Julian ;
Sklar, Pamela ;
de Bakker, Paul I. W. ;
Daly, Mark J. ;
Sham, Pak C. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 81 (03) :559-575
[10]  
Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO